AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Lokelma (sodium zirconium cyclosilicate) by Year
Lokelma (sodium zirconium cyclosilicate) — Emerging Markets YoY CER (%) (%)
AstraZeneca Lokelma (sodium zirconium cyclosilicate): 52.0% in FY2025, down 27.0 pts from a year earlier.
Where the FY2025 figure comes from
“|| Lokelma | 698 | 29 | 28 | 301 | 18 | 129 | 50 | 52 | 129 | 39 | 34 | 139 | 29 | 28”
Source: Form 6-K FY2025Q4 Earnings Release ↗
Reported in Form 6-K / 20-F Product Sales Table.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Lokelma (sodium zirconium cyclosilicate) — Emerging Markets YoY CER (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 52.0% | -27.0 pts | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 79.0% | – | Form 6-K FY2024Q4 Earnings Release ↗ |
| FY2021 | Dec 31, 2021 | -48.0% | – | Form 6-K FY2021Q4 Earnings Release ↗ |
Cite this data
StockData. (2026). AstraZeneca Lokelma (sodium zirconium cyclosilicate) (%), annual FY2021–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-lokelma-em-cer-yoy
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.
See a number that looks wrong?